Oxford Finance

Active

Website LinkedIn

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 28, 2026	Sokin	$100.0M Debt	Austin Szafranski	—
Nov 15, 2022	Renibus Therapeutics	$33.0M Debt / Other Equity	—	—
Jul 6, 2022	RefleXion Medical	$125.0M Debt	Christopher Herr	—
Jun 1, 2022	SeLux Diagnostics	$30.0M Debt	Christopher Herr	—
Feb 15, 2022	OncoResponse	$50.0M Debt	Christopher Herr	—
Nov 9, 2021	Platelet BioGenesis	$20.0M Debt	Christopher Herr	—
Nov 5, 2021	Viracta Therapeutics	$50.0M Debt	Oxford Finance, Silicon Valley Bank	—
Jul 7, 2021	Impel Pharmaceuticals	$50.0M Debt	Christopher Herr, Silicon Valley Bank	—
Jan 13, 2021	Immunocore	$175.0M Debt / Series C	BlackRock	—
Dec 8, 2020	Nature's Fynd	$45.0M Debt	Oxford Finance, Trinity Capital	—
Feb 7, 2020	Genapsys	$75.0M Other Equity	Oxford Finance	—
Sep 9, 2019	Codex DNA	$25.0M Series A	Northpond Ventures	BroadOak Capital Partners
Aug 8, 2019	ObsEva	$75.0M Debt	Christopher Herr	—
May 1, 2019	RefleXion Medical	$60.0M Debt	Oxford Finance	—
Jan 29, 2019	AliveCor	$20.0M Debt	Oxford Finance	—
Nov 29, 2018	Karius	$25.0M Debt	Christopher Herr	—
Mar 8, 2018	Xeris Biopharma	$55.0M Debt / Series C	Daniel Fero, Oxford Finance, Silicon Valley Bank	Wild Basin Investments
Apr 19, 2017	Cerapedics	$20.0M Debt	Oxford Finance	—
Aug 30, 2016	Bi02 Medical	$3.0M Debt	Oxford Finance	—
Aug 9, 2016	CVRx	$77.7M Debt / Series G	Johnson & Johnson Innovation	Action Potential Venture Capital, New Enterprise Associates, Windham Venture Partners, Ysios BioFund I
Jun 29, 2016	Monteris Medical	$10.0M Debt	Oxford Finance	—
Jan 7, 2016	Bi02 Medical	$14.0M Debt / Series D	—	—
May 13, 2015	Labcyte	$17.0M Debt	Oxford Finance, Silicon Valley Bank	—
May 13, 2015	Juventas Therapeutics	$13.5M Debt / Series B	Green Cross Holdings, POSCO Technology Investment	—
Apr 22, 2015	ReShape Medical	$12.0M Debt	—	Christopher Herr, Brett Maver